Vis enkel innførsel

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

dc.contributor.authorColagrossi, Luna
dc.contributor.authorHermans, Lucas E.
dc.contributor.authorSalpini, Romina
dc.contributor.authorDi Carlo, Domenico
dc.contributor.authorPas, Suzan D.
dc.contributor.authorAlvarez, Marta
dc.contributor.authorBen-Ari, Ziv
dc.contributor.authorBoland, Greet
dc.contributor.authorBruzzone, Bianca
dc.contributor.authorCoppola, Nicola
dc.contributor.authorSeguin-Devaux, Carole
dc.contributor.authorDyda, Tomasz
dc.contributor.authorGarcia, Federico
dc.contributor.authorKaiser, Rolf
dc.contributor.authorKöse, Sukran
dc.contributor.authorKrarup, Henrik
dc.contributor.authorLazarevic, Ivana
dc.contributor.authorLunar, Maja M.
dc.contributor.authorMaylin, Sarah
dc.contributor.authorMicheli, Valeria
dc.contributor.authorMor, Orna
dc.contributor.authorParaschiv, Simona
dc.contributor.authorParaskevis, Dimitros
dc.contributor.authorPoljak, Mario
dc.contributor.authorPuchhammer-Stoeckl, Elisabeth
dc.contributor.authorSimon, Francois
dc.contributor.authorStanojevic, Maja
dc.contributor.authorStene-Johansen, Kathrine
dc.contributor.authorTihic, Nijaz
dc.contributor.authorTrimoulet, Pascale
dc.contributor.authorVerheyen, Jens
dc.contributor.authorVince, Adriana
dc.contributor.authorLepej, Snjezana Zidovec
dc.contributor.authorWeis, Nina
dc.contributor.authorYalcinkaya, Tülay
dc.contributor.authorBoucher, Charles A. B.
dc.contributor.authorWensing, Annemarie M. J.
dc.contributor.authorPerno, Carlo F.
dc.contributor.authorSvicher, Valentina
dc.date.accessioned2018-08-15T08:33:32Z
dc.date.available2018-08-15T08:33:32Z
dc.date.created2018-08-14T11:02:44Z
dc.date.issued2018
dc.identifier.citationBMC Infectious Diseases. 2018, 18 .
dc.identifier.issn1471-2334
dc.identifier.urihttp://hdl.handle.net/11250/2558088
dc.language.isoeng
dc.relation.urihttps://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-018-3161-2
dc.titleImmune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
dc.title.alternativeImmune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber12
dc.source.volume18
dc.source.journalBMC Infectious Diseases
dc.identifier.doi10.1186/s12879-018-3161-2
dc.identifier.cristin1601864
cristin.unitcode7502,4,9,0
cristin.unitnameMolekylærbiologi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
Colagrossi_2018_HBs.pdf
Størrelse:
1.041Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel